MTOR and central nervous system cancer: The phosphoinositide 3-kinase (PI3K)/protein kinase B (PKB or AKT)/mammalian target of the rapamycin (mTOR) pathway is often dysregulated in gliomas, leading to unregulated cell growth and survival.